Skip to main content
Skip to main content
CRZNW logo

Corazon Capital V838 Monoceros Corp (CRZNW) Stock Analysis

DELISTED 2023

What happened to Corazon Capital V838 Monoceros Corp (CRZNW) stock?

Corazon Capital V838 Monoceros Corp (CRZNW) no longer trades on public markets. It was delisted in March 2023. The figures below are historical and are not a current quote.

MCap: $260M| Vol: 16.4K|
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Corazon Capital V838 Monoceros Corp (CRZNW) trades at $0.0007. Corazon Capital V838 Monoceros Corp is a blank check company focused on identifying and acquiring a business. Market cap: $260M, Sector: Financial services.

Last analyzed: Mar 17, 2026
Corazon Capital V838 Monoceros Corp is a blank check company focused on identifying and acquiring a business. Incorporated in 2021 and based in Chicago, the company aims to create value through a strategic merger or acquisition.

Analyst Coverage for CRZNW: CRZNW does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates CRZNW against Financial Services peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.

Watch the CRZNW film Every key number, told as a short cinematic story — just press play. ~2 min

Corazon Capital V838 Monoceros Corp (CRZNW) Financial Services Profile

CEOSam Yagan
HeadquartersChicago, US
IPO Year2021

Corazon Capital V838 Monoceros Corp, a special purpose acquisition company (SPAC), seeks to identify and merge with a private entity, offering investors exposure to a potentially high-growth business. Incorporated in 2021, the company operates within the financial services sector, specifically as a shell company.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 17, 2026

What Is the Investment Thesis for CRZNW?

As of Mar 17, 2026 — figures reflect the data available on that date.

Investing in Corazon Capital V838 Monoceros Corp presents a speculative opportunity tied to the management team's ability to identify and acquire a promising private company. As a SPAC, its value hinges on the potential of a future merger. The company's market capitalization is $0.26 billion. Key considerations include the management team's experience, the attractiveness of the target industry, and the terms of the eventual acquisition. The absence of current operations means the company's value is entirely dependent on its future actions. Investors should carefully assess the risks associated with SPAC investments, including the potential for dilution, the possibility of an unsuccessful acquisition, and the volatility of the stock price following a merger. The P/E ratio is -189.96, reflecting the lack of current earnings.

Based on FMP financials and quantitative analysis

CRZNW Key Highlights

Corazon Capital V838 Monoceros Corp is a blank check company, meaning its sole purpose is to acquire another company.

  • The company was incorporated in 2021, making it a relatively new entity in the SPAC market.
  • The company is based in Chicago, Illinois.
  • The market capitalization is $0.26 billion, reflecting investor expectations for a successful acquisition.
  • The P/E ratio is -189.96, indicating that the company is not currently profitable.

Who Are CRZNW's Competitors?

CRZNW is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
AONC American Oncology Network, Inc. $11.12 +0.00% $325M 50
LOCC Live Oak Crestview Climate Acquisition Corp. $10.43 -0.05% $261M 44
SLAM Slam Corp. $11.14 -0.09% $261M
TBSA TB S.A. Acquisition Corp $10.21 +0.05% $255M
ZKPU ZKPU $10.46 +4.29% $262M 63
OTGAU OTG Acquisition Corp. I Unit $10.39 +0.29% $247M 65
EVOXU Evolution Global Acquisition Corp $10.26 -0.00% $246M 63
CMII CM Life Sciences II Inc. $10.03 -0.10% $237M 65

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are CRZNW's Key Strengths?

Experienced management team

  • Access to public market capital
  • Flexibility to pursue various acquisition targets

What Are CRZNW's Weaknesses?

No current operating business

  • Dependence on identifying and acquiring a suitable target
  • Potential for dilution through additional share issuances

What Could Drive CRZNW Stock Higher?

Announcement of a definitive agreement to acquire a target company.

  • Progress in negotiations with potential acquisition targets.
  • Favorable market conditions for SPAC mergers.

What Are the Key Risks for CRZNW?

Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.

  • Failure to identify and acquire a suitable target company within the specified timeframe.
  • Dilution of shareholder value through additional share issuances.
  • Changes in regulations governing SPACs.
  • Market volatility and economic uncertainty impacting the valuation of potential targets.

What Are the Growth Opportunities for CRZNW?

  • Successful Acquisition: The primary growth opportunity lies in identifying and acquiring a high-growth potential company. The target company's industry, market position, and financial performance will drive future growth. A well-chosen target can lead to significant value creation for shareholders. The timeline for this is dependent on market conditions and the management team's deal-sourcing efforts. The market size is dependent on the sector of the acquired company.
  • Operational Improvements: After acquiring a target company, Corazon Capital can drive growth through operational improvements. This includes streamlining processes, reducing costs, and implementing new technologies. The timeline for these improvements is typically 1-3 years post-acquisition. The market size is dependent on the efficiency gains and cost savings achieved.
  • Strategic Expansion: Post-acquisition, the combined entity can pursue strategic expansion opportunities. This could involve entering new markets, launching new products, or making additional acquisitions. The timeline for expansion depends on the target company's existing capabilities and market opportunities. The market size is dependent on the specific expansion strategy.
  • Financial Engineering: Corazon Capital can employ financial engineering strategies to enhance shareholder value. This includes optimizing the capital structure, managing cash flow, and returning capital to shareholders through dividends or share repurchases. The timeline for these strategies is ongoing after the acquisition. The market size is dependent on the financial performance of the acquired company.
  • Investor Sentiment: Positive investor sentiment towards the acquired company and the SPAC structure can drive growth in the stock price. This is influenced by market conditions, industry trends, and the overall performance of the company. The timeline for this is ongoing and dependent on market dynamics. The market size is dependent on the overall investor appetite for SPACs and the acquired company's sector.

What Threats Does CRZNW Face?

  • Inability to find a suitable acquisition target
  • Increased competition from other SPACs
  • Changes in regulations governing SPACs

What Are CRZNW's Competitive Advantages?

  • Management team's experience and network
  • Access to capital through the public markets
  • Ability to identify and negotiate attractive acquisition targets

What Does CRZNW Do?

Corazon Capital V838 Monoceros Corp is a blank check company, also known as a special purpose acquisition company (SPAC). Founded in 2021 and headquartered in Chicago, Illinois, its primary objective is to identify and acquire one or more operating businesses through a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination. As a SPAC, Corazon Capital does not have any specific business operations of its own upon formation. Instead, it raises capital through an initial public offering (IPO) with the intention of using those funds to acquire a private company, thereby taking the target company public without the traditional IPO process. The company's success depends on its ability to find a suitable acquisition target and successfully negotiate a deal that is favorable to its investors. The company is led by a management team with experience in investment, operations, and deal-making. The ultimate goal is to enhance shareholder value through the successful identification, acquisition, and operation of a promising business. The company operates solely to find a target company, and its value is derived from its ability to do so.

What Products and Services Does CRZNW Offer?

  • Corazon Capital V838 Monoceros Corp is a blank check company.
  • It is a special purpose acquisition company (SPAC).
  • The company was formed to acquire one or more operating businesses.
  • It seeks to complete a merger, capital stock exchange, or asset acquisition.
  • The company raises capital through an initial public offering (IPO).
  • It aims to take a private company public through a reverse merger.

How Does CRZNW Make Money?

  • Raise capital through an initial public offering (IPO).
  • Identify and acquire a private company.
  • Take the acquired company public through a merger.
  • Generate returns for investors through the growth of the acquired company.

What Industry Does CRZNW Operate In?

Corazon Capital V838 Monoceros Corp operates within the shell company industry, a segment of the financial services sector characterized by special purpose acquisition companies (SPACs). These companies are formed to raise capital through an initial public offering (IPO) for the purpose of acquiring an existing operating company. The SPAC market has experienced periods of heightened activity and increased scrutiny. The success of a SPAC depends heavily on the management team's ability to identify and execute a value-accretive acquisition. Competitors include AONC (AonCapital Acquisition Corp), LOCC (Loch Creek), MLAI (McLaren Technology Acquisition Corp), SLAM (Slam Corp), and TBSA (TerrAscend Corp).

Who Are CRZNW's Key Customers?

  • Institutional investors
  • Retail investors
  • Private companies seeking to go public
AI Confidence: 79% Updated: Mar 17, 2026

Company Profile

Corazon Capital V838 Monoceros Corp operates in the Shell Companies industry within the Financial Services sector. It is headquartered in Chicago, US. The company is led by CEO Sam Yagan. CRZNW has traded publicly since 2021.

F-Score 2/9

Financial Health

Corazon Capital V838 Monoceros Corp's Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 25.12 places it in the safe zone, indicating low near-term bankruptcy risk.

CRZNW Financials

Bull Case vs Bear Case

Bull Case

  • Experienced management team
  • Access to public market capital
  • Flexibility to pursue various acquisition targets
  • Upcoming: Announcement of a definitive agreement to acquire a target company.

Bear Case

  • No current operating business
  • Dependence on identifying and acquiring a suitable target
  • Potential for dilution through additional share issuances
  • Potential: Failure to identify and acquire a suitable target company within the specified timeframe.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026

CRZNW Latest News

No recent news available for CRZNW.

Leadership: Sam Yagan

Unknown

Sam Yagan is a well-known entrepreneur and investor with a strong track record in the technology and internet sectors. He is a co-founder of OkCupid, a popular online dating platform, and has held leadership positions at various other companies. His experience spans from early-stage startups to large, publicly traded corporations. He has a background in mathematics and economics, providing him with a strong analytical foundation for evaluating investment opportunities. His involvement with Corazon Capital V838 Monoceros Corp suggests a focus on leveraging his expertise to identify and acquire a promising business.

Track Record: Sam Yagan's track record includes the successful launch and growth of OkCupid, which was later acquired by Match Group. He has also been involved in other successful ventures, demonstrating his ability to identify and capitalize on market opportunities. His leadership is expected to guide Corazon Capital towards a value-creating acquisition. Specific milestones under his leadership at Corazon Capital are pending, as the company is still in the acquisition phase.

Common Questions About CRZNW (Financial Services)

What happened to Corazon Capital V838 Monoceros Corp (CRZNW) stock?

Corazon Capital V838 Monoceros Corp (CRZNW) no longer trades on public markets. It was delisted in March 2023. The figures below are historical and are not a current quote.

Can I still buy CRZNW shares?

No. CRZNW stopped trading on public markets in March 2023, so the shares are not available through a broker. Anything you see quoted for CRZNW elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before CRZNW stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to Corazon Capital V838 Monoceros Corp. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

What does Corazon Capital V838 Monoceros Corp do?

Corazon Capital V838 Monoceros Corp is a special purpose acquisition company (SPAC), also known as a blank check company. Its primary purpose is to raise capital through an initial public offering (IPO) and then use those funds to acquire an existing private company. This acquisition allows the private company to become publicly traded without undergoing the traditional IPO process.

What are the main risks for CRZNW?

The main risks for Corazon Capital V838 Monoceros Corp include the failure to identify and acquire a suitable target company within the allotted timeframe, which could lead to the liquidation of the SPAC and the return of capital to shareholders. There is also the risk of overpaying for a target company, which could negatively impact shareholder value.

How is Corazon Capital V838 Monoceros Corp adapting to fintech disruption?

As a SPAC, Corazon Capital V838 Monoceros Corp's adaptation to fintech disruption is indirect, depending on the target company it chooses to acquire. If Corazon Capital acquires a fintech company or a company that is leveraging fintech solutions, it would be directly involved in the fintech space.

What regulatory challenges does Corazon Capital V838 Monoceros Corp face?

Corazon Capital V838 Monoceros Corp faces regulatory challenges common to SPACs, including compliance with SEC regulations regarding disclosures, financial reporting, and insider trading. The company must also navigate the regulatory landscape of the industry in which its target company operates.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Information is based on publicly available sources and may be subject to change.
  • AI analysis is pending and may provide further insights.
Data Sources

Popular Stocks

More Stocks We Cover